Literature DB >> 29173029

Enzymatically synthesized megalo-type isomaltosaccharides enhance the barrier function of the tight junction in the intestinal epithelium.

Hiroshi Hara1, Shunsuke Kume1, Takahisa Iizuka2, Yoshinori Fujimoto2, Atsuo Kimura1.   

Abstract

Megalo-type isomaltosaccharides are an enzymatically synthesized foodstuff produced by transglucosylation from maltodextrin, and they contain a mid-chain length polymer of D-glucose with α-1,6-glycoside linkages. The injection of a solution of megalo-type isomaltosaccharides (1-4%(w/v), average DP = 12.6), but not oligo-type isomaltosaccharides (average DP = 3.3), into the intestinal lumen dose-dependently reduced the transport rates of tight junction permeable markers in a ligated loop of the anesthetized rat jejunum. Application of the megalosaccharide also suppressed the transport of tight junction markers and enhanced transepithelial electrical resistance (TEER) in Caco-2 cell monolayers. Cholesterol sequestration by methyl-β-cyclodextrin in the Caco-2 monolayers abolished the effect of megalosaccharide. Treatment with anti-caveolin-1 and a caveolae inhibitor, but not clathrin-dependent endocytosis and macropinocytosis inhibitors, suppressed the increase in TEER. These results indicate that isomaltosaccharides promote the barrier function of tight junctions in the intestinal epithelium in a chain-length dependent manner and that caveolae play a role in the effect.

Entities:  

Keywords:  Isomaltosaccharide; caveolae; intestinal barrier; tight junction

Mesh:

Substances:

Year:  2017        PMID: 29173029     DOI: 10.1080/09168451.2017.1398065

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  1 in total

1.  A practical approach to producing isomaltomegalosaccharide using dextran dextrinase from Gluconobacter oxydans ATCC 11894.

Authors:  Weeranuch Lang; Yuya Kumagai; Juri Sadahiro; Wataru Saburi; Rakrudee Sarnthima; Takayoshi Tagami; Masayuki Okuyama; Haruhide Mori; Nobuo Sakairi; Doman Kim; Atsuo Kimura
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-13       Impact factor: 4.813

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.